|
|
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
|
5R01CA186338-03
|
$342,938
|
$342,938
|
LI, MIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
|
Yap and beta-catenin interactions in liver: Implications in Pathophysiology
|
5R01CA204586-02
|
$414,072
|
$414,072
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$14,160
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$7,200
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$15,075
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$24,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$30,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$312,001
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$9,980
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$190,300
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
Xenobiotic receptors
|
ZIA BC 005562
|
$741,267
|
$555,950
|
Gonzalez, Frank
|
CCR (NCI)
|
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$741,267
|
$444,760
|
Gonzalez, Frank
|
CCR (NCI)
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
$10,246
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
$29,827
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
$406,929
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
|
1R01CA220236-01
|
$366,000
|
$366,000
|
XIE, KEPING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Wired for Colorectal Cancer Screening: An mHealth Intervention
|
5R03CA198580-02
|
$80,489
|
$80,489
|
DAVIS, STACY
|
RBHS-SCHOOL OF PUBLIC HEALTH
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$81,420
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$252,440
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$6,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$10,208
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
$131,689
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-02
|
$2,143,077
|
$2,143,077
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
|
Washington University PDX Development and Trial Center
|
1U54CA224083-01
|
$2,424,750
|
$945,653
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
5K99CA207848-02
|
$102,298
|
$102,298
|
WARREN ANDERSEN, SHANEDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Visualization and Epigenomic Characterization of Early Intestinal Tumorigenesis in Mice
|
1R01CA212374-01
|
$434,625
|
$434,625
|
LAIRD, PETER
|
VAN ANDEL RESEARCH INSTITUTE
|
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-02
|
$176,231
|
$176,231
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-02S2
|
$25,857
|
$25,857
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-02
|
$341,981
|
$341,981
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
$238,058
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
$13,678
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
$2,199
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,151,796
|
$287,949
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-04
|
$590,334
|
$590,334
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
$118,449
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Validation of pancreatic cancer biomarkers in large prospective cohorts
|
5R01CA196286-03
|
$417,779
|
$417,779
|
LOKSHIN, ANNA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus
|
5UH2CA205105-02
|
$317,889
|
$317,889
|
WILLIS, JOSEPH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
3U01CA200466-02S1
|
$129,694
|
$129,694
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-02
|
$1,537,769
|
$1,537,769
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (Study)
|
5R01CA154823-06
|
$646,350
|
$646,350
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics
|
5R33CA177333-04
|
$298,354
|
$98,457
|
FEDERSPIEL, MARK
|
MAYO CLINIC ROCHESTER
|
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$465,962
|
$46,596
|
Hodge, James
|
CCR (NCI)
|
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$465,962
|
$93,192
|
Hodge, James
|
CCR (NCI)
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$3,750
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$953
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$128,655
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$5,000
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$70,000
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$68,830
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Using the Collaborative Cross for Model Studies of Intestinal Cancer
|
5R21CA202496-02
|
$169,650
|
$169,650
|
SIRACUSA, LINDA
|
THOMAS JEFFERSON UNIVERSITY
|
|
Total relevant funding to Digestive Diseases for this search: $532,523,882
|
